AMRX logo

Amneal Pharmaceuticals (AMRX) Selling, general & administrative expenses

annual SGA:

$476.44M+$46.76M(+10.88%)
December 31, 2024

Summary

  • As of today (May 29, 2025), AMRX annual SGA is $476.44 million, with the most recent change of +$46.76 million (+10.88%) on December 31, 2024.
  • During the last 3 years, AMRX annual SGA has risen by +$110.93 million (+30.35%).
  • AMRX annual SGA is now at all-time high.

Performance

AMRX SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

quarterly SGA:

$118.29M-$10.40M(-8.08%)
March 31, 2025

Summary

  • As of today (May 29, 2025), AMRX quarterly SGA is $118.29 million, with the most recent change of -$10.40 million (-8.08%) on March 31, 2025.
  • Over the past year, AMRX quarterly SGA has increased by +$5.69 million (+5.06%).
  • AMRX quarterly SGA is now -8.08% below its all-time high of $128.69 million, reached on December 31, 2024.

Performance

AMRX quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

TTM SGA:

-$2.35B-$13.05M(-0.56%)
March 31, 2025

Summary

  • As of today (May 29, 2025), AMRX TTM SGA is -$2.35 billion, with the most recent change of -$13.05 million (-0.56%) on March 31, 2025.
  • Over the past year, AMRX TTM SGA has dropped by -$2.79 billion (-634.73%).

Performance

AMRX TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

AMRX Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+10.9%+5.1%-634.7%
3 y3 years+30.4%+19.9%-730.3%
5 y5 years+64.5%+51.7%-931.3%

AMRX Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+30.4%-8.1%+19.9%-116.0%at low
5 y5-yearat high+64.5%-8.1%+51.7%-120.5%at low
alltimeall timeat high+336.9%-8.1%+370.9%<-9999.0%at low

AMRX Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Mar 2025
-
$118.29M(-8.1%)
$482.13M(+1.2%)
Dec 2024
$476.44M(+10.9%)
$128.69M(+8.4%)
$476.44M(+4.3%)
Sep 2024
-
$118.69M(+1.9%)
$456.75M(+1.3%)
Jun 2024
-
$116.46M(+3.4%)
$451.07M(+2.5%)
Mar 2024
-
$112.59M(+3.3%)
$440.17M(+2.4%)
Dec 2023
$429.68M(+7.5%)
$109.00M(-3.5%)
$429.68M(+1.6%)
Sep 2023
-
$113.01M(+7.0%)
$422.83M(+3.2%)
Jun 2023
-
$105.57M(+3.4%)
$409.89M(+1.7%)
Mar 2023
-
$102.10M(-0.1%)
$403.13M(+0.9%)
Dec 2022
$399.70M(+9.4%)
$102.16M(+2.1%)
$399.70M(+1.2%)
Sep 2022
-
$100.07M(+1.3%)
$394.77M(+2.2%)
Jun 2022
-
$98.81M(+0.1%)
$386.09M(+3.4%)
Mar 2022
-
$98.67M(+1.5%)
$373.44M(+2.2%)
Dec 2021
$365.50M
$97.22M(+6.4%)
$365.50M(+3.6%)
Sep 2021
-
$91.40M(+6.1%)
$352.97M(+2.4%)
Jun 2021
-
$86.16M(-5.0%)
$344.69M(+1.5%)
DateAnnualQuarterlyTTM
Mar 2021
-
$90.73M(+7.1%)
$339.48M(+3.9%)
Dec 2020
$326.73M(+12.8%)
$84.69M(+1.9%)
$326.73M(+3.4%)
Sep 2020
-
$83.12M(+2.7%)
$316.12M(+6.5%)
Jun 2020
-
$80.94M(+3.8%)
$296.80M(+4.8%)
Mar 2020
-
$77.98M(+5.3%)
$283.14M(-2.2%)
Dec 2019
$289.60M(+27.1%)
$74.08M(+16.1%)
$289.60M(+1.0%)
Sep 2019
-
$63.80M(-5.2%)
$286.75M(-3.9%)
Jun 2019
-
$67.28M(-20.3%)
$298.44M(+3.9%)
Mar 2019
-
$84.44M(+18.5%)
$287.16M(+26.0%)
Dec 2018
$227.85M(+108.9%)
$71.24M(-5.6%)
$227.85M(+24.1%)
Sep 2018
-
$75.49M(+34.8%)
$183.58M(+35.5%)
Jun 2018
-
$56.00M(+122.9%)
$135.53M(+27.3%)
Mar 2018
-
$25.12M(-6.8%)
$106.47M(+30.9%)
Dec 2017
$109.05M(-8.2%)
$26.97M(-1.7%)
$81.34M(+49.6%)
Sep 2017
-
$27.44M(+1.9%)
$54.38M(+101.9%)
Jun 2017
-
$26.94M
$26.94M
Dec 2016
$118.76M
-
-

FAQ

  • What is Amneal Pharmaceuticals annual SGA?
  • What is the all time high annual SGA for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals annual SGA year-on-year change?
  • What is Amneal Pharmaceuticals quarterly SGA?
  • What is the all time high quarterly SGA for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals quarterly SGA year-on-year change?
  • What is Amneal Pharmaceuticals TTM SGA?
  • What is the all time high TTM SGA for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals TTM SGA year-on-year change?

What is Amneal Pharmaceuticals annual SGA?

The current annual SGA of AMRX is $476.44M

What is the all time high annual SGA for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high annual SGA is $476.44M

What is Amneal Pharmaceuticals annual SGA year-on-year change?

Over the past year, AMRX annual SGA has changed by +$46.76M (+10.88%)

What is Amneal Pharmaceuticals quarterly SGA?

The current quarterly SGA of AMRX is $118.29M

What is the all time high quarterly SGA for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high quarterly SGA is $128.69M

What is Amneal Pharmaceuticals quarterly SGA year-on-year change?

Over the past year, AMRX quarterly SGA has changed by +$5.69M (+5.06%)

What is Amneal Pharmaceuticals TTM SGA?

The current TTM SGA of AMRX is -$2.35B

What is the all time high TTM SGA for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high TTM SGA is $0.00

What is Amneal Pharmaceuticals TTM SGA year-on-year change?

Over the past year, AMRX TTM SGA has changed by -$2.79B (-634.73%)
On this page